Iroko Pharmaceuticals Reports Encouraging Results from Study of Naproxen Formulated Using a Proprietary, Patented, Nanotechnology Platform - Drugs.com MedNews
Links shared publicly online about this topic.
- 600total visits
Iroko Pharmaceuticals Reports Encouraging Results from Study of Naproxen Formulated Using a Proprietary, Patented, Nanotechnology Platform - Drugs.com MedNews
First Data Reported From Iroko Research Program To Build Portfolio of Lower-Dose NSAIDs Jan 6, 2011 - Iroko Pharmaceuticals, LLC today reported the results of t
View full resource at drugs.com
Tags: Arthritis Medication, Drug, Pharma, NSAIDs, Naprosyn, Aleve, Midol Extended Relief
Most Recently Shared on January 6, 2011 at 7:00 pm By:
Iroko Pharmaceuticals Reports Encouraging Results from Study of Naproxen Formulated Using a Proprietary, P... http://bit.ly/eIqaCb #drug
Advertisement
